St. Jude Medical's CEO Discusses Q1 2012 Results - Earnings Call Transcript

St. Jude Medical (STJ)

Q1 2012 Earnings Call

April 18, 2012 8:00 am ET

Executives

Daniel J. Starks - Chairman of the Board, Chief Executive Officer and President

John C. Heinmiller - Chief Financial Officer, Principal Accounting Officer and Executive Vice President

Eric S. Fain - President of Cardiac Rhythm Management Division

Analysts

Michael N. Weinstein - JP Morgan Chase & Co, Research Division

Bruce M. Nudell - Crédit Suisse AG, Research Division

Robert A. Hopkins - BofA Merrill Lynch, Research Division

Frederick A. Wise - Leerink Swann LLC, Research Division

Kristen M. Stewart - Deutsche Bank AG, Research Division

Brooks E. West - Piper Jaffray Companies, Research Division

Presentation

Operator

Welcome to the St. Jude Medical First Quarter Earnings Conference Call. Hosting the call today is Dan Starks, Chairman, President and Chief Executive Officer of St. Jude Medical.

Before we begin, let me remind you that some of the statements made during this conference call may be considered forward-looking statements. The 10-K for fiscal year 2011 identifies certain factors that could cause the company's actual results to differ materially from those projected in any forward-looking statement made this morning. The company does not undertake to update any forward-looking statements as a result of new information or future events or development. The 10-K is available through the company or online.

During the call, non-GAAP financial measures may be used to provide information pertinent to ongoing business performance. Tables reconciling these measures to most comparable GAAP measures are available in the press release or on the St. Jude Medical website at www.sjm.com. [Operator Instructions] It is now my pleasure to turn the floor over to Dan Starks.

If you liked this article you might like

Can Abbott Outperform Despite Alere?

Abbott Shares Dip on Mixed Fourth-Quarter Earnings

Abbott Labs: Diagnosing Growth in 2017

Abbott Laboratories Can Merge With St. Jude Medical: FTC

FTC Allows Abbott to Spin Off Units, Buy St. Jude Medical